Perspective Therapeutics, Inc. (CATX)
(Delayed Data from AMEX)
$13.70 USD
+0.08 (0.59%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $13.69 -0.01 (-0.07%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/12/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | 33.33% |
ABR | 1.17 |
Earnings ESP
|
0.81% |
---|---|
Current Year | -1.02 |
Next Year | -1.07 |
EPS (TTM) | -1.00 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 0.33M | NA |
# of Estimates | NA | NA | 2 | NA |
High Estimate | NA | NA | 0.33M | NA |
Low Estimate | NA | NA | 0.33M | NA |
Year ago Sales | 2.09M | 2.19M | 1.43M | 0.33M |
Year over Year Growth Est. | NA | NA | -77.20% | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.20 | -1.02 | -1.07 |
# of Estimates | 3 | 2 | 5 | 4 |
Most Recent Consensus | -0.21 | -0.19 | -0.85 | -1.01 |
High Estimate | -0.20 | -0.19 | -0.85 | -0.88 |
Low Estimate | -0.21 | -0.20 | -1.20 | -1.40 |
Year ago EPS | -0.40 | -0.40 | -1.40 | -1.02 |
Year over Year Growth Est. | 47.50% | 50.00% | 27.14% | -5.15% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.20 | -1.02 | -1.07 |
7 Days Ago | -0.21 | -0.20 | -1.00 | -1.10 |
30 Days Ago | -0.21 | -0.20 | -1.01 | -1.13 |
60 Days Ago | 0.00 | -0.20 | -1.05 | -1.17 |
90 Days Ago | -0.25 | -0.25 | -0.90 | -1.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.19 | -0.98 | -1.01 |
Zacks Consensus Estimate | -0.21 | -0.20 | -1.02 | -1.07 |
Earnings ESP | 0.81% | 2.56% | 4.41% | 6.29% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | NA | -0.40 | -0.40 | NA |
Estimate | -0.30 | NA | -0.40 | -0.30 | NA |
Difference | 0.10 | NA | 0.00 | -0.10 | 0.00 |
Surprise | 33.33% | NA | 0.00% | -33.33% | 0.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more